Showing papers by "Mark B. Pepys published in 2020"

TL;DR: The finding that fibrils created via an in vitro amyloidogenic pathway are structurally similar to ex vivo human amyloids fibrILS does not necessarily establish that the fibrillogenic pathway is the same for both, but it narrows the current knowledge gap between in vitro models and in vivo pathophysiology.